BIOLASE INC. news, videos and press releases
For more news please use our advanced search feature.
BIOLASE INC. - More news...
BIOLASE INC. - More news...
- BIOLASE Voluntarily Initiates Chapter 11 Proceedings
- BIOLASE Reports 2024 Second Quarter Results; Achieves 40% Gross Margin as Global Consumable Sales Strengthen
- BIOLASE Announces Delisting from Nasdaq
- Biolase Reports 2024 First Quarter Results; Reiterates Full-Year 2024 Guidance For Revenue Growth and Profitability
- BIOLASE to Report First Quarter 2024 Results on May 13, 2024
- Thinking about buying stock in Xpeng, Ocugen, Quantum Computing, CONSERVATIVE BROADCAST MEDIA JOURNALISM, or BIOLASE?
- Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024
- BIOLASE to Report Fourth Quarter and Full Year 2023 Results on March 21, 2024
- Biolase Launches State-of-the-Art All-Tissue Laser System To Accelerate Adoption of Lasers in Dentistry
- Biolase Announces First Quarter 2024 Webinar Series 'Lets Talk Dental'
- BIOLASE, Inc. Announces Closing of $7.0 Million Public Offering
- BIOLASE, Inc. Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement
- BIOLASE, Inc. Announces Pricing of $7.0 Million Public Offering
- BIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024
- BIOLASE ENHANCES EDUCATION OFFERINGS IN 2024 DUE TO INCREASING DEMAND OF DENTAL LASER COURSES THROUGHOUT 2023
- BIOLASE RECEIVES SECOND TOP WORKPLACES 2023 AWARD
- BIOLASE RECEIVES TOP WORKPLACES 2023 AWARD
- BIOLASE Successfully Concludes Waterlase iPlus All Tissue Laser Trial
- BIOLASE, Inc. Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- BIOLASE REPORTS THIRD QUARTER FINANCIAL RESULTS; COMPANY BENEFITTING FROM STRATEGIC ACTIONS TAKEN TO STREAMLINE OPERATIONS AND GAIN GREATER OPERATIONAL EFFICIENCIES
- Thinking about buying stock in PaxMedica, Applied Therapeutics, Tharimmune, Singular Genomics Systems, or BIOLASE?
- Landmark Study Performed by the Independent McGuire Institute Confirms Positive 12 Month Clinical Outcomes for BIOLASE REPAIR® Perio Protocol
- BIOLASE TO REPORT THIRD QUARTER 2023 RESULTS ON NOVEMBER 9, 2023
- BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants
- Thinking about buying stock in Lithium Americas, BIOLASE, SNDL Inc, Nio Inc, or Jiuzi Holdings?
- BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants
- BIOLASE REPORTS RECORD CONSUMABLE SALES AS TOTAL SECOND QUARTER REVENUE INCREASES 17% YEAR OVER YEAR
- BIOLASE TO REPORT SECOND QUARTER 2023 RESULTS ON AUGUST 10, 2023
- BIOLASE ANNOUNCES 1-FOR-100 REVERSE STOCK SPLIT
- BIOLASE EPIC HYGIENE DENTAL LASER RECEIVES PRESTIGIOUS CELLERANT BEST OF CLASS HYGIENE AWARD
